Brief: Plx Pharma reports Q2 results
12/08/2022 11:53
Aug 12 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS SECOND QUARTER 2022 RESULTS AND PROVIDES
BUSINESS
UPDATE
* Q2 SALES $500,000
* Q2 ADJUSTED NON-GAAP LOSS PER SHARE $0.52
* Q2 GAAP LOSS PER SHARE $0.43
* CASH & CASH EQUIVALENT BALANCE OF $35.7 MILLION AS OF JUNE
30,
2022
Source text for Eikon: ID:nGNX7XrvdV
Further company coverage: PLXP.O
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice